_version_ 1783539784942092288
author Hu, Jianhua
Zhang, Xiaoli
Zhang, Xuan
Zhao, Hong
Lian, Jiangshan
Hao, Shaorui
Jia, Hongyu
Yang, Meifang
Lu, Yingfeng
Xiang, Dairong
Cai, Huan
Zhang, Shanyan
Gu, Jueqing
Ye, Chanyuan
Yu, Guodong
Jin, Ciliang
Zheng, Lin
Yang, Yida
Sheng, Jifang
author_facet Hu, Jianhua
Zhang, Xiaoli
Zhang, Xuan
Zhao, Hong
Lian, Jiangshan
Hao, Shaorui
Jia, Hongyu
Yang, Meifang
Lu, Yingfeng
Xiang, Dairong
Cai, Huan
Zhang, Shanyan
Gu, Jueqing
Ye, Chanyuan
Yu, Guodong
Jin, Ciliang
Zheng, Lin
Yang, Yida
Sheng, Jifang
author_sort Hu, Jianhua
collection PubMed
description
format Online
Article
Text
id pubmed-7255723
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72557232020-05-29 COVID-19 is more severe in patients with hypertension; ACEI/ARB treatment does not influence clinical severity and outcome Hu, Jianhua Zhang, Xiaoli Zhang, Xuan Zhao, Hong Lian, Jiangshan Hao, Shaorui Jia, Hongyu Yang, Meifang Lu, Yingfeng Xiang, Dairong Cai, Huan Zhang, Shanyan Gu, Jueqing Ye, Chanyuan Yu, Guodong Jin, Ciliang Zheng, Lin Yang, Yida Sheng, Jifang J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2020-12 2020-05-28 /pmc/articles/PMC7255723/ /pubmed/32474032 http://dx.doi.org/10.1016/j.jinf.2020.05.056 Text en © 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Hu, Jianhua
Zhang, Xiaoli
Zhang, Xuan
Zhao, Hong
Lian, Jiangshan
Hao, Shaorui
Jia, Hongyu
Yang, Meifang
Lu, Yingfeng
Xiang, Dairong
Cai, Huan
Zhang, Shanyan
Gu, Jueqing
Ye, Chanyuan
Yu, Guodong
Jin, Ciliang
Zheng, Lin
Yang, Yida
Sheng, Jifang
COVID-19 is more severe in patients with hypertension; ACEI/ARB treatment does not influence clinical severity and outcome
title COVID-19 is more severe in patients with hypertension; ACEI/ARB treatment does not influence clinical severity and outcome
title_full COVID-19 is more severe in patients with hypertension; ACEI/ARB treatment does not influence clinical severity and outcome
title_fullStr COVID-19 is more severe in patients with hypertension; ACEI/ARB treatment does not influence clinical severity and outcome
title_full_unstemmed COVID-19 is more severe in patients with hypertension; ACEI/ARB treatment does not influence clinical severity and outcome
title_short COVID-19 is more severe in patients with hypertension; ACEI/ARB treatment does not influence clinical severity and outcome
title_sort covid-19 is more severe in patients with hypertension; acei/arb treatment does not influence clinical severity and outcome
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255723/
https://www.ncbi.nlm.nih.gov/pubmed/32474032
http://dx.doi.org/10.1016/j.jinf.2020.05.056
work_keys_str_mv AT hujianhua covid19ismoresevereinpatientswithhypertensionaceiarbtreatmentdoesnotinfluenceclinicalseverityandoutcome
AT zhangxiaoli covid19ismoresevereinpatientswithhypertensionaceiarbtreatmentdoesnotinfluenceclinicalseverityandoutcome
AT zhangxuan covid19ismoresevereinpatientswithhypertensionaceiarbtreatmentdoesnotinfluenceclinicalseverityandoutcome
AT zhaohong covid19ismoresevereinpatientswithhypertensionaceiarbtreatmentdoesnotinfluenceclinicalseverityandoutcome
AT lianjiangshan covid19ismoresevereinpatientswithhypertensionaceiarbtreatmentdoesnotinfluenceclinicalseverityandoutcome
AT haoshaorui covid19ismoresevereinpatientswithhypertensionaceiarbtreatmentdoesnotinfluenceclinicalseverityandoutcome
AT jiahongyu covid19ismoresevereinpatientswithhypertensionaceiarbtreatmentdoesnotinfluenceclinicalseverityandoutcome
AT yangmeifang covid19ismoresevereinpatientswithhypertensionaceiarbtreatmentdoesnotinfluenceclinicalseverityandoutcome
AT luyingfeng covid19ismoresevereinpatientswithhypertensionaceiarbtreatmentdoesnotinfluenceclinicalseverityandoutcome
AT xiangdairong covid19ismoresevereinpatientswithhypertensionaceiarbtreatmentdoesnotinfluenceclinicalseverityandoutcome
AT caihuan covid19ismoresevereinpatientswithhypertensionaceiarbtreatmentdoesnotinfluenceclinicalseverityandoutcome
AT zhangshanyan covid19ismoresevereinpatientswithhypertensionaceiarbtreatmentdoesnotinfluenceclinicalseverityandoutcome
AT gujueqing covid19ismoresevereinpatientswithhypertensionaceiarbtreatmentdoesnotinfluenceclinicalseverityandoutcome
AT yechanyuan covid19ismoresevereinpatientswithhypertensionaceiarbtreatmentdoesnotinfluenceclinicalseverityandoutcome
AT yuguodong covid19ismoresevereinpatientswithhypertensionaceiarbtreatmentdoesnotinfluenceclinicalseverityandoutcome
AT jinciliang covid19ismoresevereinpatientswithhypertensionaceiarbtreatmentdoesnotinfluenceclinicalseverityandoutcome
AT zhenglin covid19ismoresevereinpatientswithhypertensionaceiarbtreatmentdoesnotinfluenceclinicalseverityandoutcome
AT yangyida covid19ismoresevereinpatientswithhypertensionaceiarbtreatmentdoesnotinfluenceclinicalseverityandoutcome
AT shengjifang covid19ismoresevereinpatientswithhypertensionaceiarbtreatmentdoesnotinfluenceclinicalseverityandoutcome